查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1266698

细胞分解/细胞分离的全球市场:趋势，机会，竞争分析

Cell Lysis & Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-20
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球细胞分解/细胞分离的市场规模，预计从2023年至2028年以8.3％的年复合成长率成长，到2028年达到估计53亿美元。促进市场成长的主要原因，是感染疾病数的剧增，基因学和蛋白质体学研究的政府资金增加，对个人化医疗的关注度高涨等。

本报告提供全球细胞分解/细胞分离市场调查，市场概要，市场规模和预测，趋势，促进因素、课题，各产品、各细胞类型、各用途、各最终用途产业、各地区等的分析，再加上竞争分析等资讯。

目录

第1章 摘要整理

第2章 全球细胞分解/细胞分离市场:市场动态

  • 简介，背景，及分类
  • 供应链
  • 产业的推动因素与课题

第3章 市场趋势与预测分析(2017年～2028年)

  • 宏观经济趋势(2017年～2022年)与预测(2023年～2028年)
  • 全球细胞分解/细胞分离市场趋势(2017年～2022年)与预测(2023年～2028年)
  • 全球细胞分解/细胞分离市场:各产品
    • 消耗品
      • 套件、试剂
    • 设备
      • 超音波振盪器
      • 均质机
      • 其他
  • 全球细胞分解/细胞分离市场:各细胞类型
    • 哺乳类细胞
    • 微生物细胞
    • 其他
  • 全球细胞分解/细胞分离市场:各用途
    • 蛋白质的精製、分离
    • 核酸的分离、精製
    • 其他
  • 全球细胞分解/细胞分离市场:各最终用途产业
    • 研究实验室、机关
    • 生物医药品、生物科技企业
    • 其他

第4章 市场趋势与预测分析:各地区(2017年～2028年)

  • 全球细胞分解/细胞分离市场，各地区
  • 北美的细胞分解/细胞分离市场
    • 北美的细胞分解/细胞分离市场，细胞各类型:哺乳类细胞，微生物细胞，其他
    • 北美的细胞分解/细胞分离市场，各最终用途产业:研究实验室、机关，生物医药品、生物科技企业，其他
  • 欧洲的细胞分解/细胞分离市场
    • 欧洲的细胞分解/细胞分离市场，细胞各类型:哺乳类细胞，微生物细胞，其他
    • 欧洲的细胞分解/细胞分离市场，各最终用途产业:研究实验室、机关，生物医药品、生物科技企业，其他
  • 亚太地区的细胞分解/细胞分离市场
    • 亚太地区的细胞分解/细胞分离市场，细胞各类型:哺乳类细胞，微生物细胞，其他
    • 亚太地区的细胞分解/细胞分离市场，各最终用途产业:研究实验室、机关，生物医药品、生物科技企业，其他
  • 其他地区的细胞分解/细胞分离市场
    • 其他地区的细胞分解/细胞分离市场，细胞各类型:哺乳类细胞，微生物细胞，其他
    • 其他地区的细胞分解/细胞分离市场，各最终用途产业:研究实验室、机关，生物医药品、生物科技企业，其他

第5章 竞争分析

  • 类型组合分析
  • 运用整合
  • 波特的五力分析

第6章 成长机会及策略分析

  • 成长机会分析
    • 全球细胞分解/细胞分离市场成长机会:各产品
    • 全球细胞分解/细胞分离市场成长机会:各细胞类型
    • 全球细胞分解/细胞分离市场成长机会:各用途
    • 全球细胞分解/细胞分离市场成长机会:各最终用途产业
    • 全球细胞分解/细胞分离市场成长机会:各地区
  • 全球细胞分解/细胞分离市场上新的趋势
  • 策略分析
    • 新产品的开发
    • 全球细胞分解/细胞分离市场通讯容量扩大
    • 全球细胞分解/细胞分离市场的合併，收购，及合资企业
    • 检定和授权

第7章 主要企业的企业简介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson
简介目录

Cell Lysis & Fractionation Market Trends and Forecast

The future of the global cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies. The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028 with a CAGR of 8.3% from 2023 to 2028. The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Cell Lysis & Fractionation Market by Segment

The study includes trends and forecast for the global cell lysis & fractionation market by product, cell type, application, end use industry, and region, as follows:

Cell Lysis & Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Consumables
    • Kits and Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Instruments
    • Sonicators
    • Homogenizers
    • Other Instruments

Cell Lysis & Fractionation Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Mammalian Cells
  • Microbial Cells
  • Others

Cell Lysis & Fractionation Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Protein Purification and Isolation
  • Nucleic Acid Isolation and Purification
  • Others

Cell Lysis & Fractionation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Research Laboratories and Institutes
  • Biopharmaceutical and Biotechnology Companies
  • Others

Cell Lysis & Fractionation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cell Lysis & Fractionation Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, cell lysis & fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the cell lysis & fractionation companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Cell Lysis & Fractionation Market Insights

  • Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.
  • Research laboratories and institutes are expected to witness the highest growth over the forecast period due to increasing incidence of chronic disease and rising government investment for research.
  • North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Features of the Cell Lysis & Fractionation Market

  • Market Size Estimates: Cell lysis & fractionation market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Cell lysis & fractionation market size by various segments, such as product, cell type, application, end use industry, and region
  • Regional Analysis: Cell lysis & fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different types, product, cell type, application, end use industry, and regions for the cell lysis & fractionation market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the cell lysis & fractionation market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cell lysis & fractionation market size?

Answer: The global cell lysis & fractionation market is expected to reach an estimated $5.3 billion by 2028.

Q2. What is the growth forecast for cell lysis & fractionation market?

Answer: The global cell lysis & fractionation market is expected to grow with a CAGR of 8.3% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the cell lysis & fractionation market?

Answer:The major drivers for this market are a surge in the number of infectious diseases, growing government funding for research in genomics and proteomics, and increasing focus on personalized medicine.

Q4. What are the major segments for cell lysis & fractionation market?

Answer: The future of the cell lysis & fractionation market looks promising with opportunities in the research laboratories and institutes, and biopharmaceutical and biotechnology companies.

Q5. Who are the key cell lysis & fractionation companies?

Answer: Some of the key cell lysis & fractionation companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Miltenyi Biotec
  • Becton Dickinson

Q6. Which cell lysis & fractionation segment will be the largest in future?

Answer:Lucintel forecasts that mammalian cells are expected to remain the larger type segment over the forecast period due to increasing investments by governments and private companies in cell-based research activities.

Q7. In cell lysis & fractionation market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest region over the forecast period due to rapidly growing biotechnology & pharmaceutical industries and increasing stem cell and cancer research activities.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the global cell lysis & fractionation market by product ((consumables( kits and reagents (enzymes, detergent solutions, and others)), instruments (sonicators, homogenizers, and other instruments)), cell type (mammalian cells, microbial cells, and other cells), application (protein purification and isolation, nucleic acid isolation and purification, and others), end use industry (research laboratories and institutes, biopharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cell lysis & fractionation Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Cell Lysis & Fractionation Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Cell Lysis & Fractionation Market by Product
    • 3.3.1: Consumables
      • 3.3.1.1: Kits and Reagents
        • 3.3.1.1.1: Enzymes
        • 3.3.1.1.2: Detergent Solutions
        • 3.3.1.1.3: Others
    • 3.3.2: Instruments
      • 3.3.2.1: Sonicators
      • 3.3.2.2: Homogenizers
      • 3.3.2.3.: Other Instruments
  • 3.4: Global Cell Lysis & Fractionation Market by Cell Type
    • 3.4.1: Mammalian Cells
    • 3.4.2: Microbial Cells
    • 3.4.3: Others
  • 3.5: Global Cell Lysis & Fractionation Market by Application
    • 3.5.1: Protein Purification and Isolation
    • 3.5.2: Nucleic Acid Isolation and Purification
    • 3.5.3: Others
  • 3.6: Global Cell Lysis & Fractionation Market by End Use Industry
    • 3.6.1: Research Laboratories and Institutes
    • 3.6.2: Biopharmaceutical and Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Cell Lysis & Fractionation Market by Region
  • 4.2: North American Cell Lysis & Fractionation Market
    • 4.2.1: North American Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.2.2: North American Cell Lysis & Fractionation Market by End Use Industry : Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.3: European Cell Lysis & Fractionation Market
    • 4.3.1: European Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.3.2: European Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.4: APAC Cell Lysis & Fractionation Market
    • 4.4.1: APAC Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.4.2: APAC Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others
  • 4.5: ROW Cell Lysis & Fractionation Market
    • 4.5.1: ROW Cell Lysis & Fractionation Market by Cell Type: Mammalian Cells, Microbial Cells, and Others
    • 4.5.2: ROW Cell Lysis & Fractionation Market by End Use Industry: Research Laboratories and Institutes, Biopharmaceutical and Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Type Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Application
    • 6.1.4: Growth Opportunities for the Global Cell Lysis & Fractionation Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Cell Lysis & Fractionation Market by Region
  • 6.2: Emerging Trends in the Global Cell Lysis & Fractionation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cell Lysis & Fractionation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Lysis & Fractionation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Bio-Rad Laboratories
  • 7.4: Miltenyi Biotec
  • 7.5: Becton Dickinson